Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c15f1331aa4710182da567e5517a6bfd http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_88d82639559a4046b047643cf2a33a39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_239b1fe8a19ef004b8c47c090a9c16d5 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 |
filingDate |
2005-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3b88e9665091af94158a5f084e65a5e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b640f0d8a4903baed82db58accd48f49 |
publicationDate |
2005-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2005082357-A1 |
titleOfInvention |
Use of beta-lapachone for treating hematologic tumors |
abstract |
The present invention provides for methods that utilize agents effective in the treatment of hematologic cancers and pre-cancerous hematologic cancer conditions. Moreover, the present invention provides agents capable of acting as an inhibitor of cell proliferation in hematologic cells. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8614228-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012142650-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006020719-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7812051-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7790765-B2 |
priorityDate |
2004-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |